Literature DB >> 284392

Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S.

R L Nagel, R M Bookchin, J Johnson, D Labie, H Wajcman, W A Isaac-Sodeye, G R Honig, G Schilirò, J H Crookston, K Matsutomo.   

Abstract

We have previously found that the inhibitory effect of hemoglobin F (Hb F) on the polymerization of Hb S proceeds via the formation of asymmetrical hybrid tetramers of the type alpha2betasgamma. Examination of the gelling properties of binary mixtures of Hb S and several Hb variants now shows that, among the gamma chain amino acid residues that differ from those of the beta chain, residues gamma80 (EF4) and gamma87 (F3) are at least partly responsible for this inhibition. Furthermore, we find that mixing Hb A2(alpha2delta2) with Hb S strongly inhibits gelling to an extent similar to that seen with Hb S/Hb F mixtures; this inhibition is attributable to amino acid differences between the delta and beta chain sequences at positions delta22 (B4) and delta87 (F3). Therefore, residues 22, 80, and 87 of the beta chain appear to be involved in intermolecular contact sites that stabilize the deoxy Hb S polymers.

Mesh:

Substances:

Year:  1979        PMID: 284392      PMCID: PMC383012          DOI: 10.1073/pnas.76.2.670

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  10 in total

1.  Role of hybrid tetramer formation in gelation of haemoglobin S.

Authors:  R M Bookchin; R L Nagel; T Balazs
Journal:  Nature       Date:  1975-08-21       Impact factor: 49.962

2.  The fusion of two peptide chains in hemoglobin Lepore and its interpretation as a genetic deletion.

Authors:  C BAGLIONI
Journal:  Proc Natl Acad Sci U S A       Date:  1962-11-15       Impact factor: 11.205

3.  A comparison of the functional properties of two lepore hemoglobins with those of hemoglobin A1.

Authors:  M J McDonald; R W Noble; V S Sharma; H M Ranney; J H Crookston; J M Schwartz
Journal:  J Mol Biol       Date:  1975-05-15       Impact factor: 5.469

4.  Structure of human foetal deoxyhaemoglobin.

Authors:  J A Frier; M F Perutz
Journal:  J Mol Biol       Date:  1977-05-05       Impact factor: 5.469

5.  Polymerisation of haemoglobin SA hybrid tetramers.

Authors:  R M Bookchin; T Balazs; R L Nagel; I Tellez
Journal:  Nature       Date:  1977-10-06       Impact factor: 49.962

Review 6.  Interactions between human hemoglobins: sickling and related phenomena.

Authors:  R M Bookchin; R L Nagel
Journal:  Semin Hematol       Date:  1974-10       Impact factor: 3.851

7.  Ligand-induced conformational dependence of hemoglobin in sickling interactios.

Authors:  R M Bookchin; R L Nagel
Journal:  J Mol Biol       Date:  1971-09-14       Impact factor: 5.469

Review 8.  Regulation of hemoglobin synthesis during the development of the red cell (third of three parts).

Authors:  A W Nienhuis; E J Benz
Journal:  N Engl J Med       Date:  1977-12-29       Impact factor: 91.245

9.  RATE OF SICKLING OF RED CELLS DURING DEOXYGENATION OF BLOOD FROM PERSONS WITH VARIOUS SICKLING DISORDERS.

Authors:  S CHARACHE; C L CONLEY
Journal:  Blood       Date:  1964-07       Impact factor: 22.113

10.  Comparative studies of Hb Lepore Boston, Hb A2, and Hb A.

Authors:  K Adachi; T Asakura; F M Gill; E Schwartz
Journal:  J Biol Chem       Date:  1978-01-25       Impact factor: 5.157

  10 in total
  53 in total

1.  Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers.

Authors:  Susan P Perrine; William A Wargin; Michael S Boosalis; Wayne J Wallis; Sally Case; Jeffrey R Keefer; Douglas V Faller; William C Welch; Ronald J Berenson
Journal:  J Clin Pharmacol       Date:  2011-03-21       Impact factor: 3.126

Review 2.  Sickle cell disease: old discoveries, new concepts, and future promise.

Authors:  Paul S Frenette; George F Atweh
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

Review 3.  Fetal Hemoglobin Induction by Epigenetic Drugs.

Authors:  Donald Lavelle; James Douglas Engel; Yogen Saunthararajah
Journal:  Semin Hematol       Date:  2018-04-22       Impact factor: 3.851

4.  Potential of Three Ethnomedicinal Plants as Antisickling Agents.

Authors:  Ismaila O Nurain; Clement O Bewaji; Jarrett S Johnson; Robertson D Davenport; Yang Zhang
Journal:  Mol Pharm       Date:  2016-12-05       Impact factor: 4.939

5.  Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.

Authors:  Yankai Zhang; Alireza Paikari; Pavel Sumazin; Carly C Ginter Summarell; Jacy R Crosby; Eric Boerwinkle; Mitchell J Weiss; Vivien A Sheehan
Journal:  Blood       Date:  2018-06-08       Impact factor: 22.113

6.  Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations.

Authors:  W N Poillon; B C Kim; G P Rodgers; C T Noguchi; A N Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

Review 7.  Pharmacological modification of hemoglobin F expression in sickle cell anemia: an update on hydroxyurea studies.

Authors:  S Charache
Journal:  Experientia       Date:  1993-02-15

Review 8.  Hb F in sickle cell anemia.

Authors:  A D Adekile; T H Huisman
Journal:  Experientia       Date:  1993-01-15

Review 9.  Hemoglobin variants: biochemical properties and clinical correlates.

Authors:  Christopher S Thom; Claire F Dickson; David A Gell; Mitchell J Weiss
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

10.  Retroviral transfer of a human beta-globin/delta-globin hybrid gene linked to beta locus control region hypersensitive site 2 aimed at the gene therapy of sickle cell disease.

Authors:  K J Takekoshi; Y H Oh; K W Westerman; I M London; P Leboulch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.